Medicine and Dentistry
Liver Graft
100%
Hepatitis C Virus
100%
Hepatitis C
100%
Liver Transplantation
80%
Virus RNA
40%
Peginterferon
40%
Ribavirin
40%
Patient with Transplantation
40%
Survival Analysis
20%
Univariate Analysis
20%
Treatment Duration
20%
Diabetes Mellitus
20%
Metabolic Syndrome
20%
Logistic Regression Analysis
20%
Treatment Response
20%
Multivariate Analysis
20%
Graft Survival
20%
Antiviral Therapy
20%
Virotherapy
20%
Keyphrases
Liver Transplant Recipients
100%
Sustained Virological Response
100%
Chronic Hepatitis C
100%
Orthotopic Liver Transplantation
36%
Patient Survival
27%
Ribavirin
18%
Hepatitis C Virus
18%
Hepatitis C Virus RNA
18%
Pegylated Interferon
18%
Type 1 Diabetes Mellitus (T1DM)
9%
Transplantation
9%
Metabolic Syndrome
9%
Graft Survival
9%
Antiretroviral Therapy
9%
Duration of Therapy
9%
Multivariate Analysis
9%
Obesity Diabetes
9%
Pretransplant
9%
Modifiable Risk Factors
9%
Univariate Analysis
9%
Survival Analysis
9%
Significant Predictors
9%
Response Group
9%
Predictors of Treatment Response
9%
Kaplan-Meier
9%
Multivariate Logistic Regression
9%
Liver Transplantation Outcomes
9%
Hepatitis C Virus Therapy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
100%
Hepatitis C
100%
Ribavirin
40%
Peginterferon
40%
Virus RNA
40%
Antiviral Therapy
20%
Metabolic Syndrome X
20%
Diabetes Mellitus
20%
Virotherapy
20%